Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | PRKCG | P05129 | 1/20 | 0.37 |
| ▸ | PRKCB | P05771 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKCH | P24723 | 1/20 | 0.37 |
| ▸ | PRKCI | P41743 | 1/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102064 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL7105806 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL28153716 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL7518034 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL28154768 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL28270177 | 0.98 | ACE2 (0.55) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL102836 | 0.92 | ACE2 (0.43) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL28154749 | 0.92 | ACE2 (0.48) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL1971275 | 0.92 | ACE2 (0.43) | ACE2OPRM1LMNAPRKD3PRKCG | |
| SCHEMBL5968157 | 0.91 | ACE2 (0.44) | ACE2OPRM1LMNAPRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194371-B1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2020-09-02 | — | — | EP | disclosed |
| CN-107108518-B | Antibacterial imidazolium compounds | 新加坡科技研究局 | 2020-08-11 | — | — | CN | disclosed |
| US-10570097-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-25 | — | — | US | disclosed |
| CN-106893581-B | Organic electroluminescent compounds, organic electroluminescence device and its application | 南京高光半导体材料有限公司 | 2019-11-05 | — | — | CN | disclosed |
| CN-106892915-B | Organic compound, organic electroluminescence device and its application | 南京高光半导体材料有限公司 | 2019-02-22 | — | — | CN | disclosed |
| CN-106892914-B | Organic electroluminescent compounds, organic electroluminescence device and its application | 南京高光半导体材料有限公司 | 2019-02-01 | — | — | CN | disclosed |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-17 | — | — | US | disclosed |
| US-10160728-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-12-25 | — | — | US | disclosed |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | US | disclosed |
| EP-3194371-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | Agency for Science, Technology and Research (SG) | 2017-07-26 | — | — | EP | disclosed |
| CN-101253183-A | Process for preparing optically active diphosphanes | BASF SE (DE) | 2008-08-27 | — | — | CN | disclosed |
| EP-1913007-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007012655-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2007-02-01 | — | — | WO | disclosed |
| US-5523443-A | PROTECTIVE COATINGS | CASCHEM, INC. (US) | 1996-06-04 | — | — | US | disclosed |
| US-5426132-A | Alkoxysilyl-urethane acrylate with two curing mechanisms, one activated by exposure to ultraviolet radiation, second by exposure to moisture | CASCHEM, INC. (US) | 1995-06-20 | — | — | US | disclosed |
| US-5312943-A | Protective coatings | CASCHEM, INC. (US) | 1994-05-17 | — | — | US | disclosed |
| WO-1994009013-A1 | DUAL CURING CONFORMAL COATINGS | CASCHEM, INC. (US) | 1994-04-28 | — | — | WO | disclosed |
| US-4285987-A | Process for manufacturing device with dispersion zone | ALZA CORPORATION (US) | 1981-08-25 | — | — | US | disclosed |
| US-4200098-A | Osmotic system with distribution zone for dispensing beneficial agent | ALZA CORPORATION (US) | 1980-04-29 | — | — | US | disclosed |
| US-4160020-A | CELLULOSE ESTERS, CELLULOSE ETHERS | ALZA CORPORATION (US) | 1979-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570097-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | ACE2 2828/4885OPRM1 1453/4885LMNA 1163/4885 |
| US-10160728-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | ACE2 2828/4885OPRM1 1453/4885LMNA 1163/4885 |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | ACE2 2828/4885OPRM1 1453/4885LMNA 1163/4885 |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | ACE2 2828/4885OPRM1 1453/4885LMNA 1163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.